
Erasca Investors Face August Deadline in Securities Litigation
Investors who purchased Erasca, Inc. stock between January 14, 2025, and April 26, 2026, have until August 10, 2026, to file as lead plaintiffs in a pending class action lawsuit. The case centers on allegations that the company misled shareholders regarding the development of its ERAS-0015 drug candidate.



























